Geneos Wealth Management Inc. Makes New Investment in GSK plc (NYSE:GSK)
Geneos Wealth Management Inc. purchased a new stake in shares of GSK plc (NYSE:GSK – Free Report) during the fourth quarter, ...
Bristol-Myers Squibb: Too Valuable Not To Hold This Pharma Gem, But Debt Challenges Remain
Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...
AbbVie's Skyrizi and Rinvoq Have Revived Growth Beyond Humira, Supporting a Wide Moat
AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...
money.rediff21h
GlaxoSmithKline Consumer Healthcare Ltd.
News for GlaxoSmithKline Consumer Healthcare Ltd. Google.org Grants ... to Rs 503.7 crore for the quarter ended December 2024. The company also declared a distribution of Rs... Jan 30, 2025 22:42 ...
Advanced Cervical Cancer FDA Approvals, Clinical Trials Assessment, Pipeline Insights and Companies | DelveInsight
DelveInsight’s Advanced Cervical Cancer pipeline report depicts a robust space with 70+ active players working to develop 75+ ...
Indiatimes22h
GSK Pharma Share Price Returns
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...